Battery Ventures Weighs Sale of U.K. Firm SPT Labtech
- Deal may value health-care firm at about 500 million pounds
- Battery is working with a financial adviser on potential sale
This article is for subscribers only.
Battery Ventures, a technology-focused investment firm, is considering a sale of U.K.-based life sciences firm SPT Labtech amid interest from potential buyers, according to people familiar with the matter.
Battery is working with a financial adviser on the potential sale of SPT Labtech, the people said, asking not to be identified because the matter is private. The business, which makes tools for liquid handling and sample preparation and management for scientists, could be valued at about 500 million pounds ($680 million) in a transaction, the people said.